Singapore has a strong reputation for health services and healthcare systems; in 2000, the country was ranked sixth in the world by the World Health Organization. Public hospitals have autonomy over management decisions, and compete with one another for patients. General hospitals have a variety of functions and services; they mainly represent multi-disciplinary acute inpatient and specialist outpatient services, have 24-hour emergency centers, and often specialize in a specific field of medicine (cancer research, neuroscience, dental care, cardiac care, etc.). Singapore has an array of hospitals and health services available, as well as community hospitals that exist as an intermediate form of healthcare for people who do not require the services of a general hospital but cannot cope at home.
The funding behind Singapore’s public health sector can be broken down into the Ministry of Health of Singapore, Medisave, MediShield Life, and MediFund. Singapore’s healthcare system uses a mixed financing system that includes nationalised life insurance schemes and deductions from the compulsory savings plan, or Central Provident Fund (CPF), for working Singaporeans and permanent residents.
Top 70 HealthCare Startups in Singapore:
Movinc empowers mobility by designing affordable, simple to use, compact and easy to transport mobility aids and motorised power add-ons for urban environment usage; enabling seniors and persons with mobility disabilities to live more independently, safely and healthily. They are the Most Portable and Convertible Motorised Aid you will ever need.
2. SG Meditech Pte Ltd
SG Meditech Pte Ltd is a Singapore-based medical device company that is commercializing CANULEX, a novel device that collects cord blood more efficiently and safely compared to conventional methods. The company is currently incubated under The Biofactory, an ISO 13485-certified biomedical incubator. The practice of delayed cord clamping significantly reduces the number of viable cord blood units that can be banked for future transplant use. CANULEX helps cord blood banks to minimize the impact of delayed cord clamping by maximizing the volume of cord blood that can be collected at each opportunity.
theAsianparent is the flagship brand of multinational tech and digital publishing company Tickled Media Pte. Ltd., which focuses on content and community platforms for Asian women. Starting out as a parenting blog, theAsianparent has since evolved into South East Asia’s largest platform for parents with a monthly active user reach of close to 30 million users. theAsianparent is available in 9 languages in 12 countries: Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, India, Sri Lanka, Hong Kong, Taiwan, Japan and Nigeria.
Mednefits is a B2B employee medical benefits platform that makes it easier for businesses to take care of their employees with automated, affordable, and accessible benefits. More than 1,000 health and wellness partners have joined Mednefits in Singapore and Malaysia to enhance, optimise, and disrupt the employee benefits market positively. What you need to know: – Employers can sign up for free and use Mednefits to help manage their employee benefits to save time and costs. – The platform operates on a pay-per-use basis, with no platform or contract fees. – There are no fixed plans – Mednefits works with your organisation’s existing HR policy and budget.
Docquity is a Private & Secure Continual Learning network for doctors and healthcare professionals. They work exclusively with Medical Institutions and National Medical Associations and work with doctors to provide Continuing Medical Education & Digital Conferences directly on the doctors’ mobile. “Byte sized learning delivered directly on the doctors phone”.
6. Hummingbird Bioscience
Hummingbird Bioscience is a clinical-stage biotechnology company with a proprietary Rational Antibody Discovery (RAD) platform, developing a broad pipeline of novel, precision therapeutics for the treatment of cancer and autoimmune disease. They are focused on targets with significant biological validation and disease association that have not been drugged, or are inadequately drugged to date, which they refer to as “hard targets”. Their RAD platform uses data-driven computational and systems biology with the goal of selecting promising protein targets that are associated with dysregulated biology and clinical disease, enabling us to develop antibodies that bind to specific epitopes and have the potential to be advantageous against these targets.
7. MindFi (YC S21)
MindFi’s Mission: To empower people to achieve peak mental performance. We are creating a community that helps people prioritize mental well-being. We want people to value their minds first instead of their bodies. To achieve this we have built an all-in-one employee well-being app that delivers personalized self-care recommendations, 24/7 guided support and behavioural coaches.
Zimplistic’s vision is to accelerate the world’s transition to eating healthy at home through smart technology and robotics. It’s flagship product, Rotimatic, enables users to make flatbreads with a touch of a button in flat 90 seconds. Consumerism has led to a shift in the eating habits where people are more reliant on supermarkets and frozen food because it is convenient and easy. Busy lifestyles and lack of time has led to a generation of ‘instant food’ that is loaded with preservatives and additives. With a vision of seamlessly integrating consumer robotics with IoT, we are working to bring about a day when families can eat healthy homemade meals with just the touch of a button.
9. Tessa Therapeutics Ltd
Tessa Therapeutics is a clinical-stage biotechnology company focused on cancer treatment through the development of autologous and allogeneic cell therapies for a range of cancers. Their portfolio of next-generation therapies is derived from two innovative technologies: CD30-Chimeric Antigen Receptors (CD30-CARs) and a specific subset of T cells known as Virus-Specific T Cells (VSTs). They are also developing a novel, allogeneic platform technology that combines the unique properties of CD30-CARs and VSTs. This platform anchors their next-generation off-the-shelf cell therapies against a variety of hematologic malignancies and solid tumors.
mClinica connects pharmacies using mobile technology. They improve patient health by digitizing patient programs, building the capacity of the pharmacy workforce, improving the pharmaceutical supply chain, and generating data from the smallest pharmacy to the biggest chain in Southeast Asia. They work with many of the world’s leading pharmaceutical, healthcare, and public health organizations. From their base in Singapore, they serve clients in the Philippines, Thailand, Malaysia, Indonesia, and Vietnam.
11. Test At Home Pte Ltd
Test at Home is a Biotech startup based in Singapore, with a mission to simplify diagnostics and bring it to the daily lives of people. Diagnostics first approach, anticipating and preventing diseases. Their vision: They want to revolutionize how they treat people and prevent disease by reinventing diagnostics by pinning the right problems & finding innovative solutions that can enable accuracy, efficiency & ease of use. More accurate, less expensive, and earlier diagnoses of issues will revolutionize how we treat people and prevent disease while reducing costs.
12. XCLR8 Technologies Pte. Ltd.
XCLR8 Technologies is an innovative HealthTech company that develops wARQon – Asia Regulatory and Quality Consultancy for Medical Device and Drugsearable sensors and applications to enable remote physiotherapy. They are leveraging on latest IoT technologies to increase convenience for patients, increase recovery speed and reduce costs for physical therapy. Similarly they provide a solution to practitioners to reach more patients, reduce operating costs and add additional revenue streams.
13. ARQon – Asia Regulatory and Quality Consultancy for Medical Device and Drugs
ARQon is a regulatory consultancy for medical devices, IVD’s and drug companies. They assist our clients in aspects of regulatory and quality from development to product registration submission to attain market approval in ASIA, ASEAN, EU, US, and the Rest of the World. Their team consists of professionals with broad product category experiences in medical device and drug manufacturing sites, trading industry, ex-regulators from Singapore Health Sciences Authority and trainer for Asia and ASEAN regulators. Their range of clients includes researchers, manufacturers and traders from both start-ups and MNCs.
14. Falcon Mobility Pte. Ltd.
Falcon Mobility is the Singapore’s leading company specializing in mobility scooters and motorised wheelchairs for elderly and physically disabled people.
15. Neurostyle Pte Ltd
Neurostyle Pte Ltd., is a Singapore-based medical device manufacturing company dedicated to design, development, production and supplies of Neurological diagnostic, monitoring and rehabilitation devices. Strategically located at the heart of ASEAN region, the company strives to provide excellent products and services to customers in the healthcare industry. Through Collaboration with dedicated research teams from Singapore’s Top Research Institutes and other overseas institutions that have specialized knowledge and years of experience, Neurostyle gained access to harness innovative medical device technologies through a series of flagship projects and collaboration, which in turn helps Neurostyle to implement advanced technologies into its products, hence providing customers with a variety of options to suit their needs.
16. Forefront Medical Technology
Forefront Medical Technology is a global medical device contract manufacturer with manufacturing locations in Singapore, Changzhou and Xiamen, China, as well as business development centers in Shanghai, China, Farmington, CT USA. They are located close to their customers for local, responsive technical assistance. Forefront has grown significantly during its 18 year history to become the leading contract manufacturer of the Laryngeal Mask Airway, as well a technical innovator with technical design assistance, prototyping, injection molding, extrusion, assembly, packaging and global supply chain. Their technical focus is exclusively medical disposable devices, drug delivery systems and diagnostic platforms.
Prognoix (pronounced as prognoics) is a digital medical device company that started operations in 2018 and specializes in the development of diagnostic tools for impotency. Driven by AI, our AndroCare platform facilitates reliable and objective clinical diagnosis. Their product-offering integrates well with existing clinical guidelines and pathways to facilitate seamless care management. Their vision is Utilizing technological and clinical innovations for stigmatized health conditions.
18. Acumen Research Laboratories Pte Ltd
Acumen Research Laboratories (ARL) is a contract research organization (CRO) that provides a comprehensive range of customized, high-quality contract R&D services in drug target discovery and pre-clinical drug development to support the pharmaceutical industry and related biomedical sciences research communities world-wide. The core R&D strength of ARL is in translational research that addresses the gaps in the early stages of the drug discovery and development value chain, namely novel target discovery and lead generation. The company focuses mainly on cancer, where there are significant unmet medical needs for prescribed drugs. The target identification and validation strategies of ARL comprise an integrated approach involving clinical sample analysis, systems biology, bioinformatics, genomics, proteomics, disease markers, target-specific in vitro, cell-based and in vivo studies to understand the role of the targets in the cancer.
19. Smart Thermograph PTE LTD
SMA®T Arthritis is a new patented marketing tool designed to significantly increase repeat sales of NSAIDs (i.e. ibuprofen, naproxen, diclofenac etc.) to people with knee arthritis. SMA®T Arthritis encourages a customer to proactively and more intensively use NSAID remedies in order to avoid subjective pain sensation variations. It improves brand loyalty and will allow a pharma that acquires a pool of intellectual property (IP) to • Stand out from a crowd of competitors with a unique value proposition. • Constantly promote NSAID brand via a proactive message “Prevent your pain” or “Prevent your knee joint damage”. • Reach sustainable growth of repeat sales through brand loyalty. • Win competition over manufacturers selling 2% or 3% ointments as your customer will repeatedly apply a remedy motivated by a “red spot” elimination on his knee. • Promote NSAID bundled with SMA®T Arthritis as the only smart way to treat arthritis. • Give arthritic patients an opportunity to monitor the effectiveness of NSAID.
FlexoSense is a startup with co-founders from the National University of Singapore. Their flexible sensors enable new experiences in healthcare, lifestyle, sports, robotics and more. They champion those with bold ideas with a ‘can do’ spirit in creating a difference to the daily lives of the customers. They hope to spark something remarkable in bringing together people who are committed to a common goal.
Supercraft3D is an Additive Manufacturer service bureau with focus on Healthcare and Medical applications. They offer comprehensive patient specific visualization solutions that help hospitals, doctors and the academicians get a unique perspective about the anatomy. Using sophisticated hardware and software, they are able to convert traditional X-Ray, MRI, CT and other diagnostic images into clear transparent 3D Models, at a fraction of the cost and in most cases within 24 Hrs. These models are highly accurate and help the doctor to plan a better surgery, as well as the patient to understand his anatomy before undergoing any hospitalization. These models can also act as evidence in any medico-legal situation.
AiTreat Pte Ltd is a Singapore high-tech start-up company incubated by NTUitive. AiTreat designs and integrates assistive medical robots to assist doctors/physicians to provide medical care to patients. The medical massage robot is a brand new concept. As the manpower cost further increases in Singapore and other developed countries, the therapeutic companies will be more willing to try on new products and services to reduce the heavy reliance on manpower.
Formed in 2019, through the merger of Sivantos and Widex, WS Audiology combines more than 140 years’ experience in pioneering the use of technology to help people with hearing loss hear the sounds that make life wonderful. Today, one out of three hearing aids is made by them and they are active in over 125 markets, employing 11,000 people worldwide. Their broad portfolio of leading hearing-related products and services generates annual revenues of more than € 1.7 billion. WS Audiology is privately owned by the Tøpholm and Westermann families, as well as funds under the management of EQT. As a global leader, their ambition is to unlock human potential by making wonderful sound part of everyone’s life.
By leading a new standard of maternity care, Biorithm aims to end preventable pregnancy complications & stillbirth through predictive and precision medicine. Forging new frontiers in women’s health and pregnancy care to improve outcomes globally, they have developed cutting-edge analytic software together with medical-grade wearables for accurate monitoring of a wide range of pregnancy data. Founded by doctors & engineers, Biorithm is a medical technology company, spun off from Nanyang Technological University Singapore (NTU).
25. Credo Diagnostics Biomedical
Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases, animal health and human wellness. At Credo Diagnostics Biomedical, they are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. They believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management.
26. Leben Care Technologies
Deep Learning AI healthcare startup in Ophthalmology space, developing solutions to tackle the global problem of avoidable blindness.
27. Biobot Surgical
Biobot Surgical Pte Ltd was incorporated in 2007 in Singapore, and became a member of ZIG Ventures since 2013. To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application. To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world. Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs.
The current senior care landscape is filled with costly subscription-based solutions and hidden fees, Senzehub aims to deliver an all-in-one solution to Singaporean families. They want to give independence back to seniors by allowing them to roam free and live independently, no longer stuck at home under CCTV watch – but at the same time be able to reach their designated responders and family members instantly should there be an emergency. They want to give family members the ability to focus on their children and busy working lives once again, while still being able to watch and monitor their elderly loved ones digitally without intruding privacy or leaving meetings midway to check in on them.
29. Roceso Technologies
Roceso Technologies is a Singapore based medical device company offering wearable robotic solutions to bring independence and dignity back to people’s life. Roceso Technologies aim to become a leading technology firm providing cutting-edge medical and assistive technologies
Established in Singapore since 2006, AITbiotech Pte Ltd is an ISO 13485 certified biotechnology company that develop, manufacture and supply Singapore-branded molecular diagnostic and genomic products for the international market. Its products are now sold in more than a dozen Asian countries. Apart from having a core team of experienced biotechnologists for in-house development, AITbiotech also works very closely with local scientific and medical experts such as A*STAR and NUS. AITbiotech is the first Southeast Asian Company to commercialize multiplex real-time PCR assays under the brand abTES™ for the detection of pathogens such as Influenza, Dengue, Chikungunya, Zika and Malaria.
As part of the company’s vision to provide a complete portfolio for molecular diagnostic solutions, it has its own range of instrumentation for nucleic acid extraction, PCR and real-time PCR, as well as their accompanying reagent and consumables. It is also the distributor of other life science products in Singapore including Eppendorf and New England Biolabs instrument and reagents.
31. See-Mode Technologies
See-Mode Technologies is a medtech startup backed by top tech investors across Asia-Pacific. At See-Mode, they help clinicians analyse medical images faster and more accurately and predict stroke using latest advances in machine learning and computational modelling. They have an interdisciplinary team of scientists and engineers and are advised by experienced clinicians in Australia and Singapore.
32. Curiox Biosystems
Curiox Biosystems is committed to enabling accurate biological analysis through automation. Next-generation methods and applications–including single-cell ‘omics technologies, flow cytometry, immunotherapy, and cell and gene therapy–deserve a next-generation approach to preparing samples for analysis. That’s why Curiox invented Laminar Wash technology, the only sample preparation method that eliminates centrifugation and the problems it introduces. The methodology keeps cells in their native state, improves cell retention and viability, and enhances reproducibility and miniaturization, ultimately leading to reduced costs and workflow standardization.
33. X- ZELL
X-ZELL is a global med tech start-up specialising in the isolation, digitisation and AI-guided analysis of atypical cells won from small, 8-10mL blood samples. Using a suite of patented and proprietary technologies that can be plugged into a standard pathology lab, X-ZELL’s breakthrough came in 2017 when we found a way to routinely locate tumour-associated Circulating Endothelial Cells (tCEC) in whole blood. Known to be powerful biomarkers for the early detection of clinically significant cancers, tCEC were long considered ‘undetectable’ in clinical routine. X-ZELL overcame that long-standing impasse by fusing next-generation multiplexing with cryo-technology and Artificial Intelligence – empowering scientists to identify a single tCEC among more than 5 billion healthy blood cells and visualise it on screen with never-before-seen clarity.
FathomX is a MedTech AI spin-off from the National University of Singapore and National University Health System that aims to deploy clinician friendly solutions to enhancing the existing workflow. Their first project targets public health and aims to enhance breast cancer screening with AI by significantly reducing false positive rates by 80% and enhancing the clinical workflow by cutting down the clinician number by 50%.
These are findings that have been published in the prestigious JAMA Open Network and AAAI Workshop. The company works closely with global solutions provider HP Enterprise to develop a range of technologies in the field of medical imaging and has integrated their AI engines into a technical infrastructure that is scalable, customisable and already tested out in various hospitals and clinics.
Lumiere32, a concept, an idea born in 2015, to bring the whole medical supplies ecosystem including Manufacturers, Dealers, and Clinicians on a single Omni-channel platform called Lumiere32 marketplace to save our customers’ time and money. They are a team of entrepreneurs & dental technology evangelists with medical devices & market research background who are trying to fill in the service gaps in Singapore medical devices & distribution ecosystem. Everything they do revolves around their passion with providing our customers a memorable online shopping experience. They always look to challenge traditional thinking – “We Think Bright”.
Kinexcs is a data-driven digital health company enabling personalised health for fitness seekers and athletes & evidence-based recovery for musculoskeletal patients. They are here to ease and assist all forms of recovery and rehabilitation. They want both patients and health enthusiasts to be able to take charge of their recovery or fitness goals. They aim to provide the best personalised and affordable health solutions for every individual.
Smartfuture is Singapore-based company with offices and partners in 10 cities. They provide telehealth tech solutions to healthcare providers in their own brand, so they can capture vitals of their patients and provide care remotely. There are 2 components to all our solutions – Software platform on subscription and Medical sensors and hardware that connect to the software platform. Their customers are clinics and hospitals in South East Asia and USA. Through the solutions they provide, their mission is to connect healthcare providers, insurers, employers and patients with the most advanced technology.
38. Vela Diagnostics
Vela Diagnostics is a worldwide provider of integrated molecular diagnostics workflows that address individual testing needs. Established in 2011 with its global headquarters in Singapore, Vela Diagnostics provides innovative test and data reporting solutions for Real-Time PCR and Next-Generation Sequencing. Integrating both PCR and NGS solutions to test for infectious diseases and oncologic targets increases flexibility and efficiency of the workflow and enables laboratories to overcome complex diagnostic challenges. Reliable and multi-purpose instruments help reduce cost for optimal efficiency across laboratories of all sizes. With scalability and open-channel capabilities, laboratories also benefit from the flexibility and versatility of the systems available.
Sepsitron is a Singapore based medtech startup with a vision of on-the-spot infectious disease diagnosis. At Sepsitron, they are developing a point-of-care lab-on-a-chip system with the aim of bringing centralized laboratory testing to the patient’s bedside. Their technology allows for early diagnosis, screening and treatment monitoring of suspected sepsis patients at their bedside. They are advised by expert clinicians and technical advisors and have an interdisciplinary team of researchers and engineers. Sepsitron is funded by world’s best startup accelerators – Entrepreneur First, SOSV Investments and HAX.
40. Magloy Tech
Magloy Tech is a spin-off from National University of Singapore specializing in the research & development of bioresorbable magnesium implants for orthopaedics and trauma surgery. Currently used osteosynthesis implants for fracture fixation procedures are made of titanium or steel and need to be removed by a revision surgery following healing. The revision surgery is always associated with potential risks and often trigger side effects like infections, pain and necrosis along with requiring another unpleasant hospital stay.
Magloy Tech has developed its first product, OrthoMag, after rigorous R&D with the participation of materials scientists in the field of magnesium alloys and clinical physicians from orthopedic and maxillofacial surgery that can make implant removal surgeries obsolete. Implants made of OrthoMag dissolve over time to leave only natural, healthy bone tissue and can significantly reduce post-surgery complications commonly associated with permanent bone implants.
41. Child Health Imprints
Child Health Imprints is a Singapore based start-up company established in 2018. Child Health Imprints is engaged in the development and application of cutting edge informational and computational technologies including IoT, artificial intelligence and predictive analytics to the practice of medicine in neonatal intensive care units across the world with the objective of making early diagnosis of critical diseases and improving overall quality of healthcare which is being provided to neonates.
The CHIL cloud platform also integrates laboratory results, and bedside clinical observations. It then analyses the data in medically comprehensive formats leveraging Machine Learning and Deep Learning technologis, which enhances the overall quality of healthcare provided to neonates in NICUs.
42. Aevice Health
Aevice Health Pte Ltd is a Singapore-based MedTech spin-off from Nanyang Technological University at the forefront of addressing chronic respiratory disease, one of the generation’s biggest healthcare challenges. The company’s non-invasive wearable devices enable the early detection of cardiopulmonary abnormalities remotely and in real-time, so that patients can receive fast and targeted care from the ease of their homes. Clinicians can also gain insights into their patients’ health and track their responses to treatment plans easily from the Aevice analytical platform. In Aevice Health, our mission is to drive medical innovations that transform healthcare, improve outcomes and empower lives.
Intellect is a modern-day mental health company with a mission to make mental healthcare & wellbeing support accessible for everyone. Today, Intellect is the largest and fastest growing mental health tech company in Asia, and serves over 2 million members and leading organisations globally through our mental health platform. Intellect was also selected as one of Google’s Best Apps of 2020. Intellect is backed by leading investors including Insignia Ventures Partners, Y Combinator, XA Network, and an extensive list of family offices, big tech executives & renowned angel investors.
Cover2Protect.com is a Singapore AI driven disease management startup for people with special needs around healthcare . (my)aiBUD is an AI driven preventive healthcare solution which is aiming towards decreasing the cost of healthcare by early detection and intervention. Their advanced AI engine is able to track the following parameters: ECG, PPG, SpO2, Heart Rate, Blood Pressure, and activity. They have built our machine learning models to train our AI engine (my)aiBUD to understand and learn various medical vitals like ECG , PPG , HR , BP etc in conjugations with various structured or unstructured data around a health of person.
45. Mobio Interactive
Mobio Interactive works to prevent, measure, and treat mental illness, they develop digital theragnostics personalised with objective and scalable biomarkers. They software uses facial photoplethysmography (PPG) and deep neural networks to personalise safe and effective treatments, while providing real time data on real world efficacy. The resulting gamified “measure-treat-measure” system has been clinically proven to reduce the risk of mental illness in cancer patients, as well as alleviate anxiety in young adults when compared to placebo in multiple clinical trials.26.
46. SSIVIX LAB
SSIVIX LAB work on enabling a digital health ecosystem beyond hospital and clinics. Providing smart choices of Digital Health for betterment of community. They are changing the way healthcare service receive within community. Ssivix Lab aims to help our community and citizen with respect to live smartly and digitally. Their objective to Connect all your healthcare needs at one platform using deep technology. Current in their community they are having issues in terms of seeing doctor neighborhood as waiting time is long, finding a Medical Transport as hassle to call and no price transparency, getting a right caregiver for elderly, no specific for elderly medical product and supplement, getting a home therapy for loved one. Their unique MyCLNQ application is an ecosystem for all your healthcare needs at finger tips. With the objective for betterment of the community. This breakthrough solution has in built Artificial Intelligence feature which suggest the nearest earliest available doctor and clinic availability.
ThoughtFull World Pte. Ltd. is a purpose-led digital mental health company in Asia that leverages technology, behavioural science, and evidence-based frameworks to provide affordable and accessible mental wellness solutions to corporate and educational organisations as well as consumers. ThoughtFull does this through ThoughtFullChat, a subscription-based mobile chat app that connects users to their personal certified mental health professional for daily bite-sized coaching. Through unlimited texting anytime, anywhere, Users are empowered to be their healthiest selves and Professionals are digitally-enabled to build a practice on-the-go; and ThoughtFull Education that a consulting arm that works with organisations to analyse and implement mental health programs.
Praktice.AI is an platform to find the right type of treatments and procedure for one’s health.
49. KroniKare Pte Ltd
KroniKare: Faster Recovery, Unsurpassed Efficiency! KroniKare is a highly innovative, award-winning AI-driven healthcare solution that automates the assessment & management of chronic wounds. Incorporated in Singapore, KroniKare uses thermal imaging and machine-learning algorithms running on ordinary smartphone to reduce the time taken by trained nurses to assess chronic wounds, from 30 minutes to merely 30 seconds. The technology & portability of KroniKare allow uninterrupted continuity of care for patients in different settings, from acute hospitals to rehabilitation to home care, thus reducing complications, amputations; leading to faster recovery and significant cost savings to the industry.
human (previously known as DoctorxDentist or DxD) is a medical and healthcare content platform where users like you and me are able to find accurate healthcare content. human gives you – the user – the power to decide what treatments work best for you and your conditions. They have come a long way – from a tiny blog in 2017 to the largest HON-certified health platform in Singapore today, they continue to help millions of readers get access to expert knowledge from doctors.
EndoMaster is a medical device company that is developing a novel robotic-assisted surgical system that will significantly advance current endoscopic surgeries. This will enable surgeons to perform incision-less surgery that could only be performed by open and laparoscopic surgery before. EndoMaster has developed a novel robotic-assisted surgical system for endoscopy that will significantly advance current endoscopic surgeries and enable surgeons to perform incision-less surgeries that could only be performed by open and laparoscopic surgery before. EndoMaster’s robotic system will enable minimally invasive surgery in the body with increased precision and intuitiveness and reduced surgery time. This will reduce patient discomfort as well as the risk of procedural and post-operative complications.
52. Neuroglee Therapeutics
Neuroglee Therapeutics discovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases. By combining best-in-class cognitive rehabilitation strategies and machine learning approaches, their digital therapeutic and monitoring tools empower patients, families and clinicians by helping to preserve cognition and independence. Their lead product, NG-001 is a prescription software intended for treatment of MCI and patients with early stage Alzheimer’s Disease.
53. Biolidics Limited
Biolidics Ltd, formerly known as Clearbridge BioMedics, is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. Biolidics has developed patented technology and solutions with the potential to serve as a platform technology for the diagnosis, prognosis, treatment selection and treatment monitoring of various types of cancers.
The ClearCell® FX1 System by Biolidics is a fully automated CE-IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patient’s body.
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company’s proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic.
Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDx™ system, the world’s first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate. Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field.
Started in 2012, MyDoc has become one of Asia’s top digital healthcare companies with the goal to create an efficient and effective healthcare ecosystem for patients and doctors. MyDoc offers simple, easy-to-use and time-saving services for convenient and easily accessible healthcare. MyDoc believes the key to digital health is to integrate healthcare into one, easy-to-use platform. Headquartered in Singapore, MyDoc has built a comprehensive healthcare services network across Asia that connects organisations, governments and patients to doctors, pharmacies, insurers and laboratories.
Working with their partners in Singapore, Malaysia, Sri Lanka, and other markets, MyDoc has developed a modular, easy-to-deploy solution that can be quickly tailored to solving your healthcare needs and engaging your customers in a meaningful and effective manner.
Founded in 2017, Speedoc is a virtual clinic and healthcare solutions platform that allows users to seek medical care and services from home. As a virtual clinic and hospital care provider combining physical-digital services to challenge the traditional centralized, facility-based model, Speedoc believes that this will be the solution for the aging population faced by many countries in the region as the demand for medical care increases.
Their services include house call doctors, nurses, medications delivery; and is complemented by telemedicine, remote diagnostics and health monitoring. With Speedoc, home medical services need not be limited to only certain groups of patients, but to everyday people who may require GP or A&E visits for themselves or their loved ones.
UCARE.AI aim to apply their AI’s power to accurately predict all aspects of the healthcare industry in helping patients, providers, caregivers and payers navigate each patient journey. They’re interested in your personal and professional experience. Applications from self-motivated talent with a diverse background and collaborative spirit are always welcome. You will be helping to lead healthcare to a more effective, personalised, and preventative care. Just as they value the health of the world’s people, they value that of our employees, too. They’ll support you in your individual growth and continuous learning.
Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Their goal is to extend healthy lifespan dramatically and delay age-related health issues. They identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.
Healint designs state-of-the-art solutions for chronic pain diseases to empower people by embedding AI in mobile phones and analysing in record time health data. With over 2 million registered users, Migraine Buddy is the #1 migraine app in the world. Track your migraine, understand your triggers, and share your migraine history with your doctor to get the best possible treatment. It is the most popular condition-specific app in the world. Using deep analytics and machine learning, Healint generates real-world evidence for patients, physicians, and researchers to improve treatment outcomes and expedite clinical trials.
61. Aslan Pharmaceuticals
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore.
Their leading investors are Armentum Partners, Surveyor Capital and Vivo Capital.
62. Doctor Anywhere
At Doctor Anywhere, they are guided by the core belief that healthcare should be simple, accessible and efficient for everyone. Since their launch in 2017, they’ve been disrupting the healthcare industry by developing innovative solutions to bridge gaps in the healthcare ecosystem. Their services integrate both digital and offline platforms to empower users to take charge of their health. Headquartered in Singapore, we have regional offices in Malaysia, Thailand, Philippines, Vietnam, and India, serving more than 2.5 million (and growing) users across Asia.
Their leading investors are Square Peg Capital and Kamet Capital Partners.
63. CXA Group
CXA Group is Asia’s one-stop, predictive and data intelligence platform for better health, wealth and wellness choices. Through the CXA platform, employers can empower employees with access to personalised health and lifestyle offerings, with clear and quantifiable ROI for the business. They enable employers to leverage their existing healthcare and insurance spend to pay for flexible benefits, corporate wellness and disease management initiatives in order to improve health, combat chronic disease and reduce costs while allowing for employee personalization via an e-wallet and AI.
Their leading investors are MDI Ventures, B Capital Group, Singtel Innov8 and HSBC.
Zenyum is on a mission to help Asia smile more. They’re a consumer-focused healthcare brand that removes medical jargon, cancelled appointments, price variations and puts convenience at the centre of your smile journey. Affordable dental treatment that actually works. Founded in 2018 in Singapore, Zenyum provides Smile Cosmetics, produced under the highest quality standards. Led by a team of experienced tech entrepreneurs and doctors, they bring the highest level of care to our customers by partnering with experienced local dentists across Asia. Zenyum operates in Singapore, Malaysia, Hong Kong, Indonesia, Taiwan, Thailand, and Vietnam.
Their leading investors are L Catterton Asia, RTP Global, TNB Aura and Partech.
65. Engine Biosciences
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Their proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. They are actively applying the platform internally and with partners across a range of disease indications.
Their leading investors are Polaris Partners, Baidu Ventures and EDB.
Homage is a leading technology-driven care and health services platform that combines curated and trained care professionals with smart technology to manage and provide on-demand holistic non-medical and medical services to seniors and adults, allowing them to age and recover at home with grace, control and dignity. Homage’s core care services include Disability and Care Assessments, Activities of Daily Living (ADL) assistance, Nursing Procedures and Rehabilitation services, including Physiotherapy, Speech Therapy and Occupational Therapy. Additionally, Homage Health provides health screening, mobile medicine, telemedicine, ambulance and medication delivery services.
Their leading investors are Sheares Healthcare, SeedPlus and East Ventures.
Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Founded in 2015, Holmusk is headquartered in Singapore and New York City with offices in Basel, London, Malaysia, Shanghai, and Durham (North Carolina). Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort. Holmusk’s vision is to build the world’s largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools.
Their leading investors are Optum Ventures, Health Catalyst Capital and Heritas Capital.
68. AUM Biosciences
AUM is a clinical-stage biopharmaceutical company aiming to democratize R&D with a focus on discovering, acquiring, and developing novel therapeutics in oncology. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class technologies with strong composition of matter patents in all major territories. MNK Inhibition and Multi-Kinase Inhibition (PIM/PI3K/mTOR). AUM utilizes a proprietary partnered AI-augmented platform to systematically discover and develop targeted cancer therapies focused on genetic targets. AUM’s most advanced program is Phase II ready in colorectal cancer, and 2 additional pre-clinical programs have clear pathways to orphan drug designation.
Their leading investors are Everlife and SPRIM.
DocDoc is the world’s first patient intelligence company. Their vision is to empower patients to make data-driven healthcare decisions which are safe, transparent, and fair. They use technology in conjunction with medically trained professionals to optimise healthcare outcomes and cost, and enhance the patient’s end-to-end healthcare journey. DocDoc combines AI-powered doctor discovery, telemedicine, and digital Third Party Administrator services onto a single platform. With this platform, DocDoc enables insurance companies to offer a differentiated product in a crowded market, employers to attract and retain world-class employees, and governments to improve accessibility and affordability of healthcare services for their citizens.
Their leading investors are Adamas Finance Asia, CyberPort Marco Fund and Yee How Choong.
70. Attune Technologies
Attune Technologies is a next-generation healthcare IT company that has pioneered Cloud based products designed to help the entire healthcare ecosystem. Attune’s solutions seamlessly integrate Labs, Hospitals, Pharmacies, Blood Banks, Radiology, Medical Devices (IoT), Insurance Companies, and Accounting resulting in increased revenues and operational efficiency. Attune’s solutions can be deployed across the spectrum of organizations – starting from single physician clinics to a network of healthcare providers making it the largest Cloud based healthcare IT service provider in the region. Funded by Norwest Venture Partners and Qualcomm Ventures, Attune is headquartered in Singapore and supports over 10 million patient health records serving 200+ clients spread across 15 countries in the Indian Subcontinent, South East Asia, Middle East and Africa.
Their leading investors are Norwest Venture Partners and Qualcomm Ventures.
For any corrections or nominations, Please mail firstname.lastname@example.org